Two Medtech Industry Leaders Selected to Serve on NIH HEAL Initiative® Multi-Disciplinary Working Group
Dr. Navid Khodaparast and Dr. Amy Baxter have been selected to serve on the NIH HEAL Initiative Multi-Disciplinary Working Group for four-year terms starting July 2026. The NIH HEAL Initiative is a multi-agency effort to address the nation's overdose epidemic and chronic pain crisis.
Two prominent leaders in the medical technology industry have been selected to serve on the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (NIH HEAL Initiative) Multi-Disciplinary Working Group (MDWG). Dr. Navid Khodaparast, Chief Science Officer and Co-Founder of Spark Biomedical, and Dr. Amy Baxter, CEO and Founder of Harmonic Scientific, will serve four-year terms beginning July 2026. The NIH HEAL Initiative, launched in 2018, is a multi-agency effort led by the National Institute on Drug Abuse and the National Institute of Neurological Disorders and Stroke to address the nation's overdose epidemic and chronic pain crisis. Dr. Khodaparast leads clinical research on noninvasive transcutaneous auricular neurostimulation for opioid withdrawal and chronic pain. Dr. Baxter has developed noninvasive medical technologies, including VibraCool and Buzzy, to reduce opioid use and needle pain. The MDWG provides strategic input on research priorities and program development across the HEAL portfolio.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.